The role of medicinal plants in the management of hepatocellular carcinoma and its metastasis
Open Access
- 24 August 2025
- journal article
- Published by Open Exploration Publishing in Exploration of digestive diseases
- Vol. 4, 100588
Abstract
Hepatocellular carcinoma (HCC) ranks as the sixth most diagnosed cancer and the third most common cancer-related death globally. The underlying precise molecular mechanisms for its progression remain poorly understood. Interestingly, approximately 90% of HCC-related deaths are not due to the primary tumor itself but rather to its difficult-to-treat metastatic spread. Despite sorafenib being the first-line therapy for HCC, challenges such as drug resistance, frequent recurrence, and metastasis contribute to poor prognosis. In this context, alternative therapeutic strategies are urgently needed. A broad spectrum of phytochemicals, including polyphenolic derivatives, flavonoids, carotenoids, alkaloids, terpenes, lignans, and saponins, has shown considerable promise as potential anti-cancer agents, both in vitro and in vivo. These natural plant-derived compounds exhibit distinct and overlapping mechanisms of action, characterized by their antioxidant, anti-inflammatory, and anti-cancer properties, offering a novel approach to HCC treatment. An extensive literature search was conducted from 2010 to 2024 using reputable electronic databases such as MEDLINE, Embase, Google Scholar, Science Direct, and other reliable sources using different keywords, including HCC, medicinal plants in HCC, HCC metastasis, and mechanism of action of medicinal plants in HCC, among others. This comprehensive review aims to summarize the potential role of plant-based bioactive components in combating HCC through various cellular mechanisms, highlighting their therapeutic potential in the management of both primary and metastatic disease.Keywords
This publication has 144 references indexed in Scilit:
- Silibinin, a potential fasting mimetic, inhibits hepatocellular carcinoma by triggering extrinsic apoptosisMedcomm, 2024
- Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodiesClinical Liver Disease, 2022
- Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinomaIUBMB Life, 2021
- Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular CarcinomaClinical Liver Disease, 2021
- Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivoMolecular Carcinogenesis, 2017
- Picroside II Protects Rat Lung and A549 Cell Against LPS-Induced Inflammation by the NF-κB PathwayInflammation, 2017
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety dataHepatology, 2016
- Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial–mesenchymal transition: Partial mediation by the transcription factor NFAT1Molecular Carcinogenesis, 2013
- CURCUMIN: THE INDIAN SOLID GOLD2007
- Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinomaLiver Transplantation, 2004